BioSpace News Archive

Biovica, active in cancer diagnostics, announced that Henrik Winther was appointed SVP Business Development and will be part of the management team.

The board of directors of Medtronic plc (NYSE:MDT) today approved the fiscal year 2020 third quarter cash dividend of $0.54 per ordinary share, representing an 8 percent increase over the prior year.

Calithera Biosciences, Inc. (Nasdaq: CALA), today announced that preliminary safety and efficacy data from an investigator-sponsored trial evaluating telaglenastat (CB-839) in combination with azacitidine will be presented in an oral session at the American Society of Hematology (ASH) Annual Meeting 2019 taking place December 7-10, in Orlando, Florida.

Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), and Inceptua Medicines Access (a business unit of the Inceptua Group), today announced that they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.

Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological and neuropsychiatric diseases, today announced successful completion of a pre-planned interim futility analysis for the T2 Protect AD Study

Assembly Biosciences, Inc. (Nasdaq: ASMB), today announced that Richard Colonno, PhD, Executive Vice President and Chief Scientific Officer Virology, will present a Plenary Lecture, “Eliminating Residual HBV Replication – A Critical Gateway to Cure” at the HEP DART Meeting on Tuesday, Dec 10, 2019 at 5:30pm HST in Kauai, HI.

Enteris BioPharma, Inc., a biotechnology company developing innovative drug products built around its proprietary delivery technologies and a wholly-owned subsidiary of SWK Holdings Corporation (SWKH.OB), congratulates Cara Therapeutics on the successful completion of its Phase 2 clinical trial of Oral KORSUVA

The Supreme Cannabis Company, Inc. (“Supreme Cannabis” or the “Company”) (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) announced today the strengthening of its Board of Directors (the “Board”) with the intention to appoint a new independent director, Jackie Poriadjian-Asch, on and effective December 10, 2019.

Technavio has announced its latest market research report titled global assistive technology market 2020-2024.

Gemphire Therapeutics Inc. (NASDAQ:GEMP) announced today that, based upon the final vote count certified by the independent inspector of elections for the annual meeting of stockholders held December 6, 2019, its stockholders approved all of the merger-related proposals,